EAPC 2020: The Evaluation of Cannabinoids Is Feasible in Patients With Advanced Cancer
Cannabidiol and tetrahydrocannabinol will be assessed as single agents in this population.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.